Cargando…
Can Control Infections Slow Down the Progression of Alzheimer’s Disease? Talking About the Role of Infections in Alzheimer’s Disease
Alzheimer’s disease as the most common age-related dementia affects more than 40 million people in the world, representing a global public health priority. However, the pathogenesis of Alzheimer’s disease (AD) is complex, and it remains unclear. Over the past decades, all efforts made in the treatme...
Autores principales: | Shi, Mingchao, Li, Chunrong, Tian, Xiaoping, Chu, Fengna, Zhu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339924/ https://www.ncbi.nlm.nih.gov/pubmed/34366826 http://dx.doi.org/10.3389/fnagi.2021.685863 |
Ejemplares similares
-
Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease
por: Zhu, Feiqi, et al.
Publicado: (2020) -
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab
por: Shi, Mingchao, et al.
Publicado: (2022) -
Synchronizing an aging brain: can entraining circadian clocks by food slow Alzheimer’s disease?
por: Kent, Brianne A.
Publicado: (2014) -
Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer’s Disease?
por: Fulop, Tamas, et al.
Publicado: (2018) -
Structural Connectivity in Down Syndrome and Alzheimer’s Disease
por: Saini, Fedal, et al.
Publicado: (2022)